The FedEx Global Healthcare Quality Program was recognised at the 34th CNS Partnership Conference, certifying the strength of FedEx’s quality management system and its ability to deliver end-to-end logistics services for the pharmaceutical industry.
Nick Gennari, President of Global Healthcare and Commercial Sales at FedEx said: “This pioneering, network-wide approach to quality showcases our commitment to complying with the highest standards in the industry for the transportation and handling of global pharmaceutical products. With over 90% of our global healthcare volume moving through facilities that are now CEIV Pharma-certified, we are providing our customers with outstanding quality solutions in the global pharma air space.”
Frederic Leger, Senior Vice President Commercial Products and Services at IATA said: “As global supply chains become more complex, the need for consistent, trusted standards is greater than ever for the safety of the end consumers. We are pleased to see FedEx Global Healthcare certify additional facilities with CEIV Pharma, the industry’s trusted mark of quality and excellence in the handling of pharmaceuticals.”
FedEx’s hubs in Memphis and Indianapolis were CEIV Pharma-certified in 2024, along with the ramps in San Juan and Aguadilla, both in Puerto Rico.
The new certificate covers 15 facilities across Europe, the Americas and Asia.
Across Europe, FedEx has CEIV Pharma in Cologne, Frankfurt, Liege, Milan Malpensa and Paris Charles de Gaulle.
In the Americas, the certificate covers Greensboro, Los Angeles, Miami, Newark, Oakland, San Jose in Costa Rica and Santo Domingo in the Dominican Republic.
Guangzhou and Osaka are the Asian hubs with CEIV Pharma certification.